HIMS Valuation

Hims & Hers Health Inc

Add to Watchlist

Advanced Chart

45.080

-0.94(-2.043%)1D

Overview
Forecast
Valuation
Earnings

HIMS Relative Valuation

HIMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HIMS is overvalued; if below, it's undervalued.

Historical Valuation

Hims & Hers Health Inc (HIMS) is now in the Fair zone, suggesting that its current forward PS ratio of 4.02 is considered Fairly compared with the five-year average of -5.35. The fair price of Hims & Hers Health Inc (HIMS) is between 10.38 to 59.12 according to relative valuation methord.

Relative Value

Fair Zone

10.38-59.12

Current Price：45.08

Fair

60.55

Trailing

Forward

31.22

EV/EBITDA

Hims & Hers Health Inc. (HIMS) has a current EV/EBITDA of 31.22. The 5-year average EV/EBITDA is 2.25. The thresholds are as follows: Strongly Undervalued below -78.60, Undervalued between -78.60 and -38.17, Fairly Valued between 42.68 and -38.17, Overvalued between 42.68 and 83.10, and Strongly Overvalued above 83.10. The current Forward EV/EBITDA of 31.22 falls within the Historic Trend Line -Fairly Valued range.

55.21

EV/EBIT

Hims & Hers Health Inc. (HIMS) has a current EV/EBIT of 55.21. The 5-year average EV/EBIT is -0.69. The thresholds are as follows: Strongly Undervalued below -90.22, Undervalued between -90.22 and -45.45, Fairly Valued between 44.08 and -45.45, Overvalued between 44.08 and 88.84, and Strongly Overvalued above 88.84. The current Forward EV/EBIT of 55.21 falls within the Overvalued range.

4.02

Hims & Hers Health Inc. (HIMS) has a current PS of 4.02. The 5-year average PS is 3.36. The thresholds are as follows: Strongly Undervalued below -2.06, Undervalued between -2.06 and 0.65, Fairly Valued between 6.08 and 0.65, Overvalued between 6.08 and 8.79, and Strongly Overvalued above 8.79. The current Forward PS of 4.02 falls within the Historic Trend Line -Fairly Valued range.

25.69

P/OCF

Hims & Hers Health Inc. (HIMS) has a current P/OCF of 25.69. The 5-year average P/OCF is -3.86. The thresholds are as follows: Strongly Undervalued below -113.62, Undervalued between -113.62 and -58.74, Fairly Valued between 51.03 and -58.74, Overvalued between 51.03 and 105.91, and Strongly Overvalued above 105.91. The current Forward P/OCF of 25.69 falls within the Historic Trend Line -Fairly Valued range.

42.66

P/FCF

Hims & Hers Health Inc. (HIMS) has a current P/FCF of 42.66. The 5-year average P/FCF is 7.87. The thresholds are as follows: Strongly Undervalued below -120.78, Undervalued between -120.78 and -56.46, Fairly Valued between 72.19 and -56.46, Overvalued between 72.19 and 136.52, and Strongly Overvalued above 136.52. The current Forward P/FCF of 42.66 falls within the Historic Trend Line -Fairly Valued range.

Hims & Hers Health Inc (HIMS) has a current Price-to-Book (P/B) ratio of 18.46. Compared to its 3-year average P/B ratio of 9.54 , the current P/B ratio is approximately 93.63% higher. Relative to its 5-year average P/B ratio of 5.64, the current P/B ratio is about 227.11% higher. Hims & Hers Health Inc (HIMS) has a Forward Free Cash Flow (FCF) yield of approximately 1.27%. Compared to its 3-year average FCF yield of 1.11%, the current FCF yield is approximately 14.65% lower. Relative to its 5-year average FCF yield of -0.68% , the current FCF yield is about -287.97% lower.

18.46

P/B

Median3y

9.54

Median5y

5.64

1.27

FCF Yield

Median3y

1.11

Median5y

-0.68

Competitors Valuation Multiple

The average P/S ratio for HIMS's competitors is 1.76, providing a benchmark for relative valuation. Hims & Hers Health Inc Corp (HIMS) exhibits a P/S ratio of 4.02, which is 128.31% above the industry average. Given its robust revenue growth of 72.61%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

HIMS.N

Hims & Hers Health Inc

Encompass Health Corp

Fresenius Medical Care AG

0.63

5.84%

14.72B

Performance Decomposition

Market capitalization of HIMS increased by 212.42% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 4.21 to 7.80.

The secondary factor is the Revenue Growth, contributed 72.61%to the performance.

Overall, the performance of HIMS in the past 1 year is driven by Margin Expansion. Which is more sustainable.

72.61%

315.65M → 544.83M

Revenue Growth

85.27%

4.21 → 7.80

Margin Expansion

54.54%

37.75 → 58.34

P/E Change

212.42%